⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIST News
Milestone Pharmaceuticals Inc. Common Shares
Form 8-K
sec.gov
MIST
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
globenewswire.com
MIST
Form 8-K
sec.gov
MIST
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
MIST
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
globenewswire.com
MIST
Mistral Inc. Awarded U.S. Army Contract to Provide THOR Group 2 UAS Systems in Support of Company-Level Small UAS Needs
prnewswire.com
MIST
ESLT
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
globenewswire.com
MIST
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
MIST
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MIST
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
globenewswire.com
MIST